Wells Fargo
EXAS

Wells Fargo’s Exact Sciences EXAS Stock Holding History

Wells Fargo’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,000
Closed -$345K – 7068
2024
Q1 		$345K Buy
+5,000
New +$316K ﹤0.01% 4135
2021
Q4 		– Sell
-2,100
Closed -$200K – 7367
2021
Q3 		$200K Buy
+2,100
New +$222K ﹤0.01% 5093

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Wells Fargo's EXAS Position: Q1 2026 in Review

Wells Fargo sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 52,183 shares — an estimated $5.3M sold.

Wells Fargo first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $282M in Q2 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Wells Fargo reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Wells Fargo sold 52,183 Exact Sciences shares in Q1 2026, an estimated $5.3M.
  • Wells Fargo first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Wells Fargo's Exact Sciences position peaked at $282M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.